Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 5, 2009, Pages 529-538

  Potter, Mona P ^a   Liu, Howard Y ^a   Monuteaux, Michael C ^a   Henderson, Carly S ^a   Wozniak, Janet ^a   Wilens, Timothy E ^a   Biederman, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CLONAZEPAM; CLONIDINE; DEXAMPHETAMINE; GUANFACINE; LITHIUM; LORAZEPAM; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PALIPERIDONE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; ZIPRASIDONE;

ACNE; ADOLESCENT; ANXIETY DISORDER; APPETITE; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HAIR DISEASE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MANIA; MIXED ANXIETY AND DEPRESSION; MONOTHERAPY; NAUSEA; PEDIATRIC HOSPITAL; POLYDIPSIA; POLYURIA; PRESCHOOL CHILD; PRESCRIPTION; SCHOOL CHILD; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOCIAL ASPECT; TREATMENT RESPONSE; TREMOR; UNIVERSITY HOSPITAL; WEIGHT GAIN;

ADOLESCENT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; OUTPATIENT CLINICS, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 70449397332     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0142     Document Type: Article

References (85)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR). Washington (DC): American Psychiatric Association, 2000.
3. Axelson D, Birmaher B, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S, Bridge J, Keller M: Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 63:1139-1148, 2006. (Pubitemid 44498393)
4. Barzman DH, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Campbell P, Strakowski SM: The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: A retrospective chart review. J Child Adolesc Psychopharmacol 14:593-1600, 2004.
5. Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM: The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol 16:665-670, 2006.
6. Biederman J, Faraone S, Mick E, Wozniak J, Chen L, Ouellette C, Marrs A, Moore P, Garcia J, Mennin D, Lelon E: Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 35:997-1008, 1996.
7. Biederman J, Mick E, Bostic JQ, Prince J, Daly J, Wilens TE, Spencer T, Garcia-Jetton J, Russell R, Wozniak J, Faraone SV: The naturalistic course of pharmacologic treatment of children with maniclike symptoms: A systematic chart review. J Clin Psychiatry 59:628-637; quiz 638, 1998.
8. Biederman J, Faraone SV, Chu MP, Wozniak J: Further evidence of a bidirectional overlap between juvenile mania and conduct disorder in children. J Am Acad Child Adolesc Psychiatry 38:468-476, 1999.
9. Biederman J, Faraone SV, Wozniak J, Monuteaux MC: Parsing the association between bipolar, conduct, and substance use disorders: A familial risk analysis. Biol Psychiatry 48:1037-1044, 2000a.
10. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV: Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 10:185-192, 2000b.
11. Biederman J, McDonnell MA, Wozniak J, Spencer T, Aleardi M, Falzone R, Mick E: Aripiprazole in the treatment of pediatric bipolar disorder: A systematic chart review. CNS Spectr 10:141-148, 2005a.
12. Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J: Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschoolage children. Biol Psychiatry 58:589-594, 2005b.
13. Biederman J, Mick E, Wozniak J, Aleardi M, Spencer T, Faraone SV: An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 15:311-317, 2005c. (Pubitemid 40734110)
14. Biederman J, Mick E, Spencer T, Dougherty M, Aleardi M, Wozniak J: A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord 9:888-894, 2007a. (Pubitemid 350215115)
15. Biederman J, Mick E, Spencer T, Doyle R, Joshi G, Hammerness P, Kotarski M, Aleardi M, Wozniak J: An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr 12:683-689, 2007b. (Pubitemid 47571968)
16. Birmaher B, Kennah A, Brent D, Ehmann M, Bridge J, Axelson D: Is bipolar disorder specifically associated with panic disorder in youths? J Clin Psychiatry 63:41-419, 2002.
17. Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyegar S, Keller M: Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 63:175-183, 2006. (Pubitemid 43213879)
18. Borchardt CM, Bernstein GA: Comorbid disorders in hospitalized bipolar adolescents compared with unipolar depressed adolescents. Child Psychiatry Hum Dev 26:11-18, 1995.
19. Carlson GA, Kelly KL: Manic symptoms in psychiatrically hospitalized children-What do they mean? J Affect Disord 51:123-135, 1998.
20. Chang K, Saxena K, Howe M: An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45:298-304, 2006.
21. Conners CK, Barkley RA: Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 21:809-843, 1985.
22. Correll CU: Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry 46:687-700, 2007.
23. Correll CU: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry 69(Suppl 4):26-36, 2008.
24. Craney JL, Geller B: A prepubertal and early adolescent bipolar disorder-I phenotype: Review of phenomenology and longitudinal course. Bipolar Disord 5:243-256, 2003.
25. Danielyan A, Pathak S, Kowatch RA, Arszman SP, Johns ES: Clinical characteristics of bipolar disorder in very young children. J Affect Disord 97:51-59, 2007.
26. DelBello MP, Kowatch RA, Warner J, Schwiers ML, Rappaport KB, Daniels JP, Foster KD, Strakowski SM: Adjunctive topiramate treatment for pediatric bipolar disorder: A retrospective chart review. J Child Adolesc Psychopharmacol 12:323-330, 2002a.
27. Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM: A double- blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41:1216-1223, 2002b.
28. DelBello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 45:305-313, 2006.
29. Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE, Calabrese JR: Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895-901, 2003.
30. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR: Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:409-417, 2005.
31. Findling RL, McNamara NK, Stansbrey R, Gracious BL, Whipkey RE, Demeter CA, Reed MD, Youngstrom EA, Calabrese JR: Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J Am Acad Child Adolesc Psychiatry 45:142-148, 2006.
32. Findling RL, Short EJ, McNamara NK, Demeter CA, Stansbrey RJ, Gracious BL, Whipkey R, Manos MJ, Calabrese JR: Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit= hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:1445-1453, 2007.
33. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonalez- Heydrich J, Risser RC, Nowlin ZM: A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11:239-250, 2001.
34. Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM: The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 61:9-15, 2000.
35. Geller B, Fox LW, Clark KA: Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry 33:461-468, 1994.
36. Geller B, Sun K, Zimerman B, Luby J, Frazier J, Williams M: Complex and rapid-cycling in bipolar children and adolescents: A preliminary study. J Affect Disord 34:259-268, 1995.
37. Geller B, Bolhofner K, Craney JL, Williams M, DelBello MP, Gundersen K: Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry 39:1543-1548, 2000a.
38. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, Delbello MP, Soutullo CA: Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157-164, 2000b.
39. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL: Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 158:125-127, 2001. (Pubitemid 32047258)
40. Geller B, Tillman R, Craney JL, Bolhofner K: Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry 61:459-467, 2004. (Pubitemid 38620844)
41. Geller B, Tillman R, Bolhofner K, Zimerman B: Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry 65:1125-1133, 2008.
42. Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Nierenberg AA, Miyahara S, Sachs G: Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv 57:660-665, 2006.
43. Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS: Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: Findings From the STEP-BD. Am J Psychiatry 166:173-181, 2009.
44. Goldstein TR, Birmaher B, Axelson D, Goldstein BI, Gill MK, Esposito-Smythers C, Ryan ND, Strober MA, Hunt J, Keller M: Psychosocial functioning among bipolar youth. J Affect Disord 114:174-183, 2009.
45. Harpold TL, Wozniak J, Kwon A, Gilbert J, Wood J, Smith L, Biederman J: Examining the association between pediatric bipolar disorder and anxiety disorders in psychiatrically referred children and adolescents. J Affect Disord 88:19-26, 2005.
46. Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM: Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J Am Acad Child Adolesc Psychiatry 40:1448-1456, 2001a. (Pubitemid 34250965)
47. Kafantaris V, Dicker R, Coletti DJ, Kane JM: Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania. J Child Adolesc Psychopharmacol 11:409-413, 2001b. (Pubitemid 34117290)
48. Keck PE, Jr., Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R: Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100- week, double-blind study versus placebo. J Clin Psychiatry 68:1480-1491, 2007.
49. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ: Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39: 713-720, 2000.
50. Kowatch RA, Sethuraman G, Hume JH, Kromelis M, Weinberg WA: Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 53:978-984, 2003.
51. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M: Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44: 213-235, 2005a.
52. Kowatch RA, Youngstrom EA, Danielyan A, Findling RL: Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord 7:483-496, 2005b.
53. Kowatch RA, DelBello MP: Pediatric bipolar disorder: emerging diagnostic and treatment approaches. Child Adolesc Psychiatr Clin N Am 15:73-108, 2006.
54. Leverich GS, Post RM, Keck PE, Jr., Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D: The poor prognosis of childhoodonset bipolar disorder. J Pediatr 150:485-490, 2007.
55. Lewinsohn PM, Klein DN, Seeley JR: Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 34:454-463, 1995.
56. Masi G, Mucci M, Millepiedi S: Clozapine in adolescent inpatients with acute mania. J Child Adolesc Psychopharmacol 12:93-99, 2002.
57. Masi G, Perugi G, Millepiedi S, Toni C, Mucci M, Pfanner C, Berloffa S, Pari C, Akiskal HS: Bipolar co-morbidity in pediatric obsessive-compulsive disorder: Clinical and treatment implications. J Child Adolesc Psychopharmacol 17:475-486, 2007.
58. McClellan J, Kowatch R, Findling RL: Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 46:107-125, 2007.
59. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M: National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 64:1032-1039, 2007.
60. Pavuluri MN, Graczyk PA, Henry DB, Carbray JA, Heidenreich J, Milklowitz DJ: Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: Development and preliminary results. J Am Acad Child Adolesc Psychiatry 43:528-537, 2004a.
61. Pavuluri MN, Henry DB, Carbray JA, Sampson G, Naylor MW, Janicak PG: Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 82(Suppl 1):S103-S111, 2004b.
62. Pavuluri MN, Henry DB, Devineni B, Carbray JA, Naylor MW, Janicak PG: A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 43:859-867, 2004c.
63. Pavuluri MN, Birmaher B, Naylor MW: Pediatric bipolar disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 44:846-871, 2005.
64. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA: Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 55:875-881, 2004. (Pubitemid 38526299)
65. Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE, Jr.: Atypical antipsychotics in the treatment of mania: A meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 67:509-516, 2006.
66. Post RM, Chang KD, Findling RL, Geller B, Kowatch RA, Kutcher SP, Leverich GS: Prepubertal bipolar I disorder and bipolar disorder NOS are separable from ADHD. J Clin Psychiatry 65:898-902, 2004.
67. Reich W, Neuman RJ, Volk HE, Joyner CA, Todd RD: Comorbidity between ADHD and symptoms of bipolar disorder in a community sample of children and adolescents. Twin Res Hum Genet 8:459-466, 2005.
68. Scheffer RE, Kowatch RA, Carmody T, Rush AJ: Randomized, placebo- controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 162:58-64, 2005.
69. Spencer TJ, Biederman J, Wozniak J, Faraone SV, Wilens TE, Mick E: Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders. Biol Psychiatry 49:1062-1070, 2001.
70. Suppes T, Eudicone J, McQuade R, Pikalov A, 3rd, Carlson B: Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. J Affect Disord 107:145-154, 2008.
71. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J: Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 164:1547-1556, 2007.
72. Vieta E, Bourin M, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Swanink R, Iwamoto T: Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: Double-blind, randomised, comparative 12-week trial. Br J Psychiatry 187:235-242, 2005.
73. West AE, Henry DB, Pavuluri MN: Maintenance model of integrated psychosocial treatment in pediatric bipolar disorder: A pilot feasibility study. J Am Acad Child Adolesc Psychiatry 46:205-212, 2007.
74. West SA, McElroy SL, Strakowski SM, Keck PE, Jr., McConville BJ: Attention deficit hyperactivity disorder in adolescent mania. Am J Psychiatry 152:271-273, 1995a.
75. West SA, Strakowski SM, Sax KW, Minnery KL, McElroy SL, Keck PE, Jr.: The comorbidity of attention-deficit hyperactivity disorder in adolescent mania: Potential diagnostic and treatment implications. Psychopharmacol Bull 31:347-351, 1995b.
76. Wilens TE, Spencer T, Biederman J, Wozniak J, Connor D: Combined pharmacotherapy: An emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 34:110-112, 1995.
77. Wilens TE, Biederman J, Forkner P, Ditterline J, Morris M, Moore H, Galdo M, Spencer TJ, Wozniak J: Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. J Child Adolesc Psychopharmacol 13:495-505, 2003a.
78. Wilens TE, Biederman J, Kwon A, Chase R, Greenberg L, Mick E, Spencer TJ: A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 13:143-152, 2003b.
79. Wilens TE, Biederman J, Adamson JJ, Henin A, Sgambati S, Gignac M, Sawtelle R, Santry A, Monuteaux MC: Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: A controlled study. Drug Alcohol Depend 95:188-198, 2008.
80. Wozniak J, Biederman J: A pharmacological approach to the quagmire of comorbidity in juvenile mania. J Am Acad Child Adolesc Psychiatry 35:826-828, 1996. (Pubitemid 26174617)
81. Wozniak J, Biederman J, Kiely K, Ablon JS, Faraone SV, Mundy E, Mennin D: Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 34:867-876, 1995.
82. Wozniak J, Biederman J, Faraone SV, Blier H, Monuteaux MC: Heterogeneity of childhood conduct disorder: further evidence of a subtype of conduct disorder linked to bipolar disorder. J Affect Disord 64:121-131, 2001. (Pubitemid 32324205)
83. Wozniak J, Biederman J, Monuteaux MC, Richards J, Faraone SV: Parsing the comorbidity between bipolar disorder and anxiety disorders: A familial risk analysis. J Child Adolesc Psychopharmacol 12:101-111, 2002.
84. Wozniak J, Monuteaux M, Richards J, K EL, Faraone SV, Biederman J: Convergence between structured diagnostic interviews and clinical assessment on the diagnosis of pediatric-onset mania. Biol Psychiatry 53:938-944, 2003.
85. Wozniak J, Biederman J, Kwon A, Mick E, Faraone S, Orlovsky K, Schnare L, Cargol C, van Grondelle A: How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol Psychiatry 58:583-588, 2005.